Kiora Pharmaceuticals, Inc. Common Stock (KPRX) is a publicly traded Healthcare sector company. As of May 21, 2026, KPRX trades at $2.64 with a market cap of $11.12M and a P/E ratio of -1.01. KPRX moved +0.40% today. Year to date, KPRX is +25.71%; over the trailing twelve months it is -15.33%. Its 52-week range spans $1.76 to $4.18. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces KPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kiora Pharmaceuticals, Inc. Common Stock (KPRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KPRX moved +0.40% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.64 |
| Market Cap | $11.12M |
| P/E Ratio | -1.01 |
| EPS | $-2.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.18 |
| 52-Week Low | $1.76 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.84M |
| Gross Margin | 0.00% |
1 analysts cover KPRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.